Literature DB >> 21676982

Benign tertian malaria--a misnomer?

Chanaveerappa Bammigatti1, Sirish Shetty, Seema Shetty, Ashwini Kumar.   

Abstract

Plasmodium vivax usually causes an acute self-limiting febrile illness with fever spikes on every third day and no complications or death. Therefore the illness caused by this parasite was termed benign tertian malaria. However, many complications associated with Plasmodium falciparum have been seen with increasing frequency with Plasmodium vivax in recent times. The present study highlights the various complications associated with Plasmodium vivax malaria.

Entities:  

Mesh:

Year:  2011        PMID: 21676982     DOI: 10.1258/td.2011.110025

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  5 in total

1.  Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes.

Authors:  Wenn-Chyau Lee; Benoit Malleret; Yee-Ling Lau; Marjorie Mauduit; Mun-Yik Fong; Jee Sun Cho; Rossarin Suwanarusk; Rou Zhang; Letusa Albrecht; Fabio T M Costa; Peter Preiser; Rose McGready; Laurent Renia; Francois Nosten; Bruce Russell
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

2.  Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria?

Authors:  Antonio M Quispe; Edwar Pozo; Edith Guerrero; Salomón Durand; G Christian Baldeviano; Kimberly A Edgel; Paul C F Graf; Andres G Lescano
Journal:  Am J Trop Med Hyg       Date:  2014-04-21       Impact factor: 2.345

3.  Malaria and the conducting system of the heart.

Authors:  Smitha Bhat; Madhu Kumar; Jayaprakash Alva
Journal:  BMJ Case Rep       Date:  2013-01-29

4.  Severe Plasmodium vivax malaria among sudanese children at New Halfa Hospital, Eastern Sudan.

Authors:  Hyder Mahgoub; Gasim I Gasim; Imad R Musa; Ishag Adam
Journal:  Parasit Vectors       Date:  2012-07-30       Impact factor: 3.876

5.  Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010.

Authors:  Daniel Parker; Rujira Lerdprom; Wanna Srisatjarak; Guiyun Yan; Jetsumon Sattabongkot; James Wood; Jeeraphat Sirichaisinthop; Liwang Cui
Journal:  Malar J       Date:  2012-08-21       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.